Extensive Checklist to cGMP Inspections in Pharmaceutical Manufacturing Plants

cGMP inspections are an essential part of ensuring that pharmaceutical companies produce high-quality, safe, and effective drugs. These inspections help maintain the integrity of the pharmaceutical supply chain and protect public health. Pharmaceutical companies must prioritize continuous cGMP compliance, prepare thoroughly for inspections, and respond promptly to any observations made by inspectors to remain in good standing with regulatory authorities. Here's a comprehensive cGMP inspection checklist for a pharmaceutical company, incorporating requirements from USFDA, EMA, WHO, UKMHRA, TGA, and ANVISA. This checklist includes a rating system to evaluate compliance with each requirement.现行药品生产质量管理规范（current Good Manufacturing Practices，简称cGMP）检查是保障制药企业生产高质量、安全且有效的药品的核心环节。此类检查有助于维护制药供应链的完整性，守护公众健康权益。制药企业必须始终将持续符合cGMP要求作为首要任务，为检查做好充分筹备，并及时回应检查人员提出的各项检查缺陷项，以维持与监管机构的良好合规关系。 本文提供一份面向制药企业的全面cGMP检查清单，整合了美国食品药品监督管理局（U.S. Food and Drug Administration，USFDA）、欧洲药品管理局（European Medicines Agency，EMA）、世界卫生组织（World Health Organization，WHO）、英国药品和医疗产品监管署（Medicines and Healthcare products Regulatory Agency，UKMHRA）、澳大利亚治疗产品管理局（Therapeutic Goods Administration，TGA）以及巴西卫生监督局（Agência Nacional de Vigilância Sanitária，ANVISA）的相关监管要求。本清单设置了评分体系，用于评估各项要求的符合程度。